| Address: | 333 Lakeside Dr, Foster City, CA 94404, USA |
|---|---|
| Postal code: | 94404 |
| Phone: | (650) 574-3000 |
| Website: | http://www.vosevi.com/contact-us |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Vosevi, use the form below and your opinion, advice or comment will appear in this space.
Phone. (650) 574-3000. Fax. (650) 578-9264. VOSEVI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1, 2, 3, 4, 5, or 6 infection with or without cirrhosis (compensated) who have previously been treated with a Hep C regimen containing an NS5A...
Vosevi is the latest single-tablet regimen in Gilead's portfolio of sofosbuvir-based DAA treatments that offer people living with HCV a short course of therapy to cure their HCV, with the convenience Gilead Sciences, Inc. Investors Sung Lee, 650-524-7792 or Media Mark Snyder, 650-522-6167.
The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, and Tybost for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, and Hepsera products for...
- Vosevi is Gilead's Fourth Sofosbuvir-Based Treatment to Receive CHMP Positive Opinion for the Treatment of Chronic HCV Infection -. Gilead Sciences, Inc. Investors Sung Lee, +1 650-524-7792 or Media (U.S.) Mark Snyder, +1 650-522-6167 or Media (Europe) Arran Attridge, +44 (208) 587-2477.
The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, and Tybost for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, and 1-650-574-3000.
(650) 574-3000. • Chronic hepatitis C (HCV) product sales , which consist of Epclusa ® (sofosbuvir 400 mg/velpatasvir 100 mg), Harvoni ® (ledipasvir 90 mg/sofosbuvir 400 mg), Vosevi ® (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) and Sovaldi ® (sofosbuvir 400 mg), were $902 million for...
The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands.
Registrant's telephone number, including area code: 650-574-3000. • Vosevi is an oral formulation of a once-daily, single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment of HCV infection in adults with genotype 1, 2, 3, 4, 5 or 6 previously treated with an NS5A...
The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. +1.650.574.3000. Number of Employees.
Vosevi is the latest single-tablet regimen in Gilead's portfolio of sofosbuvir-based DAA treatments that offer people living with HCV a short course of therapy to cure their HCV, with the convenience Gilead Sciences, Inc. Investors Sung Lee, 650-524-7792 or Media Mark Snyder, 650-522-6167.